Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Reviews in Clinical and Experimental Pharmacology is Scopus-indexed (Q2, CiteScore 4.1), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 2772-4328Verify ISSN ↗2772-4336Verify ISSN ↗
Publisher: Bentham Science Publishers
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (all) | 22 / 79 | 72nd | Q2 |
| Pharmacology (medical) | 131 / 278 | 53rd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 4.1.
Current Reviews in Clinical and Experimental Pharmacology is Q2 in Pharmacology, Toxicology and Pharmaceutics (all) (rank 22 of 79) and Q2 in Pharmacology (medical) (rank 131 of 278), by CiteScore 2025.
Current Reviews in Clinical and Experimental Pharmacology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.1, which places it in quartile Q2 at the 72nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.550, quartile Q2, with an H-index of 52.
Current Reviews in Clinical and Experimental Pharmacology is published by Bentham Science Publishers. Its print ISSN is 2772-4328 and its online ISSN is 2772-4336.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Reviews in Clinical and Experimental Pharmacology has an h-index of 58 and a 2-year mean of 2.42 citations per paper (OpenAlex). Its Scopus CiteScore is 4.1, quartile Q2. On 2-year citations it ranks #24 of 77 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (all).
Current Reviews in Clinical and Experimental Pharmacology published 24 papers in 2025; its busiest recent year was 2020 with 62. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2022–2026), authors are most often from India (28.9%), Iran (18.2%) and United States (10.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.